Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Blueprint Medicines Corporation BPMC

Set alert

Price alert · BPMC

All alert types
129.46 0.00 0.00%

At close · Jul 18

129.46 Day range 129.46

52-week range unavailable

YTD
+48.43%
1 year
+13.20%
Open
129.46
Prev close
129.46
Mkt cap
8.36B
Vol
2.98M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
129.46
High
129.46
Forward P/E
-137.72
Beta
0.83
Short ratio
0.62
Inst. own
109.19%
Dividend
0.00
Ex-div date
50-d avg
120.02
200-d avg
100.22
1y target
130.29

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Jun 3, 2025Downgrade: Wolfe Research · Outperform → Peer Perform
  • Jun 3, 2025Downgrade: JMP Securities · Market Outperform → Market Perform
  • Jun 4, 2025Rating: Citigroup · Sell → Neutral
  • Jun 5, 2025Rating: UBS · Neutral → Neutral
  • Jun 5, 2025Rating: Morgan Stanley · Equal-Weight → Equal-Weight
  • Jun 17, 2025Downgrade: Wells Fargo · Overweight → Equal-Weight
Signals (7)
NameDateAgo
MACD: Sell SignalJun 18, 20251 year ago
MACD: Buy SignalJun 2, 20251 year ago
RSI: OverboughtJun 2, 20251 year ago
MACD: Sell SignalMay 23, 20251 year ago
RSI: OverboughtMay 1, 20251 year ago
SMA: BullishApr 28, 20251 year ago
SMA: BullishApr 25, 20251 year ago

Analyst view

Consensus: hold

Hold
Price target (mean) 130.29 +0.6% upside
Target (low)
129.00
Target (mean)
130.29
Target (high)
135.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 19
  • 2 months ago 21
  • 3 months ago 21

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BPMC analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.38-0.38 – -0.38-0.80+52.5%174.80M+26.5%1
Next quarter-0.11-0.11 – -0.11-0.89+87.6%195.00M+52.1%1
Current year-0.71165-2.84 – 2.92-3.83+81.4%723.30M+42.2%7
Next year1.151.15 – 1.15-0.71165+261.6%1.02B+40.3%1

Upgrades and downgrades

The latest rating changes

BPMC analyst upgrades and downgrades
DateFirmActionFromTo
Jun 17, 2025Wells FargoDowngradeOverweightEqual-Weight
Jun 5, 2025Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jun 5, 2025UBSMaintainedNeutralNeutral
Jun 4, 2025CitigroupUpgradeSellNeutral
Jun 3, 2025JMP SecuritiesDowngradeMarket OutperformMarket Perform
Jun 3, 2025Wolfe ResearchDowngradeOutperformPeer Perform
Jun 2, 2025ScotiabankDowngradeSector OutperformSector Perform
Jun 2, 2025JP MorganDowngradeOverweightNeutral
Jun 2, 2025WedbushDowngradeOutperformNeutral
Jun 2, 2025NeedhamDowngradeBuyHold
May 2, 2025HC Wainwright & Co.ReiteratedBuyBuy
Apr 28, 2025NeedhamMaintainedBuyBuy
Apr 16, 2025WedbushReiteratedOutperformOutperform
Apr 8, 2025NeedhamReiteratedBuyBuy
Mar 17, 2025JefferiesInitiated—Buy
Mar 7, 2025ScotiabankInitiated—Sector Outperform
Mar 3, 2025Citizens Capital MarketsReiteratedMarket OutperformMarket Outperform
Feb 14, 2025JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Feb 14, 2025NeedhamReiteratedBuyBuy
Feb 14, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 13, 2025NeedhamReiteratedBuyBuy
Feb 4, 2025JP MorganMaintainedOverweightOverweight
Jan 27, 2025Piper SandlerMaintainedNeutralNeutral
Jan 15, 2025JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Jan 13, 2025WedbushReiteratedOutperformOutperform
Jan 13, 2025NeedhamReiteratedBuyBuy
Jan 2, 2025Stephens & Co.ReiteratedOverweightOverweight
Dec 17, 2024NeedhamReiteratedBuyBuy
Dec 11, 2024GuggenheimReiteratedBuyBuy
Dec 9, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform